mRNA |
CAL-101 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.09 |
mRNA |
momelotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.06 |
0.09 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.09 |
mRNA |
Mitomycin-C |
GDSC1000 |
pan-cancer |
AAC |
0.06 |
0.09 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.09 |
mRNA |
Fumonisin B1 |
CTRPv2 |
pan-cancer |
AAC |
-0.064 |
0.09 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.09 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.054 |
0.09 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.09 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.09 |